This inventor holds 4 USPTO granted patents. Top assignee: Women's and Children's Hospital. Active years: 1998-2003.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 1998-2003
Title: The Innovative Journey of Teresa Occhiodoro
Introduction: Teresa Occhiodoro is a notable inventor based in Prospect, AU. With a remarkable portfolio of four patents, she has made significant contributions to the field of enzymatic research. Her work focuses on enhancing enzyme functionality, particularly in the context of iduronate 2-sulfatase.
Latest Patents: Among her latest innovations is the patent for "Glycosylation Variants of Iduronate 2-Sulfatase." This invention presents a highly glycosylated iduronate-2-sulfatase enzyme that consists of a polypeptide with at least 5 kilodaltons more sugar than the version purified from natural sources, such as the human liver. Additionally, this patent includes the development of an enzymatically active polypeptide fragment or variant of the highly glycosylated enzyme. The invention also covers an isolated nucleic acid encoding iduronate-2-sulfatase, along with an expression vector, a host cell, and a method for producing the highly glycosylated enzyme.
Career Highlights: Teresa is affiliated with the Women's and Children's Hospital, where her research and development endeavors have flourished. Her innovative spirit is reflected not just in her patents, but also in her commitment to advancing scientific understanding of enzyme behaviors and modifications.
Collaborations: Throughout her career, Teresa has collaborated with esteemed colleagues such as Peter J. Wilson and Charles Phillip Morris. These partnerships highlight her ability to work alongside other competent professionals in the field, further enhancing the impact of her inventions.
Conclusion: The accomplishments of Teresa Occhiodoro serve as a testament to her ingenuity and dedication in the realm of enzymatic research and innovation. With her focus on enhancing iduronate-2-sulfatase, she continues to pave the way for future advancements in biochemistry and medicine.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile